CompletedPhase 4ketamine
Management of Pain in Lumbar Arthrodesis
Sponsored by Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
NCT ID
NCT04751175
Target Enrollment
128 participants
Start Date
2013-07-04
Est. Completion
2025-12-31
About This Study
KETAMINE AND DEXAMETASONE IN THE MANAGEMENT OF PAIN IN LUMBAR ARTHRODESISPhase IV prospective randomized controlled single-center clinical trial to determine the effect of intravenous ketamine and dexamethasone administration perioperatively in patients undergoing lumbar arthrodesis.
Conditions Studied
Interventions
- •Ketamine
- •Dexamethasone
- •Physiologic saline
Eligibility
Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria: * Male or female * Age\> 18 years * ASA I-III. * Lumbar arthrodesis. * Patients who have signed the preoperative informed consent for participation in the study. Exclusion Criteria: * Unstable coronary heart disease * Glaucoma * History of allergy to ketamine, dexamethasone, or morphic chloride * Dementia or inability to understand IC and study * Pluricomplicated diabetes mellitus difficult to control * Patients who have taken an experimental drug 30 days before the start of the study or who are included in any type of study of an experimental drug
Study Locations (1)
Hospital Dr Josep Trueta
Girona, Spain